The health crisis we face today is an unprecedented challenge for our society. American companies have taken immediate action to not only protect their employees, support communities in Europe, and around the world, but also to develop innovative solutions to address the global emergency. At the same time, AmCham EU member companies are striving to preserve business continuity in a safe and responsible manner.
Take a look at some of their stories.
The health crisis we face today is an unprecedented challenge for our society. American companies have taken immediate action to not only protect their employees, support communities in Europe, and around the world, but also to develop innovative solutions to address the global emergency. At the same time, AmCham EU member companies are striving to preserve business continuity in a safe and responsible manner.
Take a look at some of their stories.
Healthcare companies are using their expertise to develop COVID-19 vaccine candidates as well as medicines that can be used in prevention and management of serious consequences related to COVID-19. Many of them have also significantly increased their production of medicines, medical devices and personal protective equipment.
Additional resources for supporting health workers in the front lines are also contributed by companies that have not traditionally been active in the healthcare sector. Many have found creative ways of contributing their skills and infrastructures, by re-purposing their facilities and technologies. For example, companies with 3D printing technologies have begun to produce face shields; producers of spirits, perfumes and cosmetics are contributing to the production of hand sanitiser; transport companies are utilising their aircraft and vehicle fleets to transport equipment to areas in need. New technological solutions to track, map and use computing capabilities are continuously developed to support communities, researchers and governments to address and better understand some of the impacts of COVID-19.
Finally, to support global relief efforts companies have pledged to support the United Nations COVID-19 Solidarity Response Fund, and other similar initiatives, created to address communities in need and the requirements of healthcare workers on the frontlines. Companies are also creating grants and programmes to assist small businesses likely to be impacted most in this crisis.
Tackling this global pandemic, and its health and socio-economic effects, requires strong cooperation between government, business and civil society. We all have a role to play. Find out more from our COVID-19 portal.
:focal())
The review of the Cybersecurity Act (CSA 2.0) is an opportunity to build a more coherent, outcome-oriented EU cybersecurity framework. While the proposal recognises fragmentation across the Single Market, further simplification is needed to reduce overlaps and support effective compliance.
A harmonised approach to risk assessment and supervision can strengthen resilience while avoiding duplicative obligations. Certification and supply-chain measures should remain risk-based, objective, technical and aligned with international standards. Structured industry engagement and clear designation thresholds under the ICT Supply Chain Framework and a secure-by-design approach to policymaking will be essential to support cybersecurity and global interoperability. Read more on how CSA 2.0 can strengthen resilience across the Single Market.
:focal())
From Monday, 27 to Wednesday, 29 April, AmCham EU travelled to Paris, France and the European Parliament in Strasbourg, France for a series of meetings on EU financial services policy developments. The delegation engaged with representatives from French and European financial authorities, Members of the European Parliament, Accredited Parliamentary Assistants and Group Policy Advisers, to share business perspectives on the EU’s financial services agenda. Discussions focused on how to improve Europe’s competitiveness, deepen capital markets and create the right conditions for innovation in digital finance. Members also highlighted the need for more coherent and interoperable rules that reduce complexity while encouraging long-term investment through risk-based regulation.
:focal())
On Tuesday, 28 to Wednesday, 29 April, AmCham EU travelled to the European Parliament in Strasbourg, France for a series of meetings with policymakers to discuss ongoing EU healthcare policy initiatives. The delegation met with Members of the European Parliament, Accredited Parliamentary Assistants and Group Policy Advisers, to discuss priorities for the EU’s health agenda. This included exchanges on how to strengthen Europe’s life sciences competitiveness and support resilient supply chains. Members also stressed the need for urgent action to simplify overlapping rules and reduce complexity. They underlined that proportionate, risk-based regulation is essential to support innovation. This approach can also help ensure timely patient access to medicines, medical technologies and diagnostics.
Insights and advocacy driving Europe’s policy agenda. Our priorities support growth, innovation and a stronger transatlantic economy.
Connecting business and policymakers to strengthen the voice of American companies in Europe.